Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study

Anita van de Munckhof, Mayte Sanchez van Kammen, Turgut Tatlisumak, Katarzyna Krzywicka, Sanjith Aaron, Florina Antochi, Antonio Arauz, Miguel A. Barboza, Adriana B. Conforto, Daniel Galdames Contreras, Mirjam R. Heldner, Maria Hernandez-Perez, Sini Hiltunen, Xunming Ji, Wayneho Kam, Timothy J. Kleinig, Espen S. Kristoffersen, Ronen R. Leker, Robin Lemmens, Sven PoliMohammad Wasay, Teddy Wu, Niluefer Yesilot, Jian Chen, Maria Sofia Cotelli, Jelle Demeestere, Jiangang Duan, Nesrin Ergin, Tiago Esteves Freitas, Ana Gomes, Heleen M. den Hertog, Erik Lindgren, Nicolas Martinez-Majander, Issa Metanis, Angel Miraclin, Lucia Jansi Rani, Y. Muralidhar Reddy, Adrian Scutelnic, Sathish Shanmugasundaram, Ido R. van den Wijngaard, Isil Yazici Gencdal, Rik van Eekelen, Jelle Vellema, Marcel Arnold, Lia Neto, Saskia Middeldorp, Diana Aguiar de Sousa, Katarina Jood, Jukka Putaala, Jose M. Ferro, Jonathan M. Coutinho

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalLancet Neurology
Volume24
Issue number3
Pages (from-to)199-207
Number of pages9
ISSN1474-4422
DOIs
Publication statusPublished - Mar 2025
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Rivaroxaban
  • Definition
  • Safety
  • 3124 Neurology and psychiatry

Cite this